{"symbol":"ABBV","fiscalQuarter":"Q4-2018","reportDate":"2019-01-25","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2018","postBrief":{"headline":"AbbVie Misses on EPS \u2014 Stock Down 6.22%","keyNumbers":[{"metric":"EPS","actual":"$1.90","expected":"N/A","surprise":"-3.61%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced in the quarter.","They emphasized a focus on long-term growth despite current setbacks."],"summary":"Management expressed concerns over recent performance but remains committed to their strategic goals. They did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report indicates a slight miss on EPS, which contributed to a significant drop in stock price by 6.22%. Investors reacted negatively, likely due to the lack of revenue data and no guidance for future performance. The management's defensive tone suggests they are aware of current challenges but remain focused on long-term objectives.","metaDescription":"AbbVie Inc (ABBV) Q4 2018 earnings: EPS missed expectations. Stock down 6.22%. Full breakdown."}}